GILEAD SCIENCES, INC. Debt Instrument, Redemption Price, Percentage
GILEAD SCIENCES, INC. (GILD) reported Debt Instrument, Redemption Price, Percentage of 101.00% for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-05.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentRedemptionPricePercentage · last filed 2014-11-05
- GILEAD SCIENCES, INC. debt instrument, redemption price, percentage for the quarter ending 2014-03-31 was 101.00%.
| Period end | Debt Instrument, Redemption Price, Percentage 3 month | Debt Instrument, Redemption Price, Percentage 6 month | Debt Instrument, Redemption Price, Percentage 9 month |
|---|---|---|---|
| 2014-09-30 | 101.00% 10-Q · filed 2014-11-05 | ||
| 2014-06-30 | 101.00% 10-Q · filed 2014-08-04 | ||
| 2014-03-31 | 101.00% 10-Q · filed 2014-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |